ORIGINAL RESEARCH article
Front. Med.
Sec. Dermatology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1653347
Lichen sclerosus and the association with subsequent psychiatric disorders
Provisionally accepted- 1Universitat zu Lubeck Institut fur Experimentelle Dermatologie, Lübeck, Germany
- 2Universitatsklinikum Schleswig-Holstein Campus Lubeck, Lübeck, Germany
- 3Universitatsklinikum Schleswig-Holstein Campus Lubeck Institut fur Ernahrungsmedizin, Lübeck, Germany
- 4Karolinska Institutet (KI), Solna, Sweden
- 5Karolinska Universitetssjukhuset, Stockholm, Sweden
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Lichen sclerosus (LS) is an acquired, non-communicable, chronic inflammatory disease that predominantly affects the genital area and may lead to substantial impairment in quality of life. While some studies reported elevated rates of depression and anxiety among patients with LS, the available evidence is limited by often small sample sizes, cross-sectional designs, narrow matching, and limited consideration of sex-or race-disparities. Moreover, the risk of a broader spectrum of psychiatric disorders remains insufficiently characterized. Objective: To evaluate the risk of a larger spectrum of psychiatric disorders following a diagnosis of LS in a retrospective cohort study. Methods: The US Collaborative Network of TriNetX was used to create a propensity-score-matched cohort of individuals with LS and non-LS controls (n=42,581 per cohort). Risk of psychiatric disorders following the index events was analyzed in a retrospective cohort study. Several sensitivity analyses were conducted to assess robustness of the findings. Subgroup analyses were performed to identify potential sex-or racial-disparities. Results: Within five years, 3.92% of patients with LS as opposed to 3.43% of controls were subsequently diagnosed with a depressive episode (HR 1.31, CI 1.22-1.40, p<0.0001). Furthermore, risks of recurrent major depression (HR 1.71, CI 1.48-1.98, p<0.0001) and reaction to severe stress (HR 1.62, CI 1.45-1.80, p<0.0001) were increased in patients with LS. These risks seemed more pronounced in those of White ethnicity and in women. Risks for suicidal ideations, suicide attempts, and schizophrenia were not different between patients and matched controls. Conclusion: Patients with LS are at a moderately increased risk of depression and stress-related psychiatric disorders.
Keywords: psychiatric disease, Lichen sclerosus, TriNetX, cohort study, Mental Health, Depression
Received: 24 Jun 2025; Accepted: 09 Oct 2025.
Copyright: © 2025 Alfarsi, Recke, Bieber, Thaci, Ludwig and Curman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Philip Curman, philip.curman@ki.se
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.